trevitherapeutics.com - TRVI Profit before payment of interest, taxes and amortization
Trevi Therapeutics focuses on developing targeted treatments for pruritus and cough, leveraging profits from Haduvio sales to patients with neurological pathologies. EBITDA analytics visualize the cash flow, where 0.00 determines this parameter level. The company's contract manufacturing capacities are fully prepared to scale up drug production volumes following the completion of clinical stages.
Trevi Therapeutics, Inc. (TRVI) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- business book valuation details:
- business debt structure and liquidity details:
Aggregate Debt to Capital Trevi Therapeutics|TRVI - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Trevi Therapeutics Inc|TRVI - Company Aggregate Debts|Debts to Book Value Trevi Therapeutics|TRVI - Company Long-Term Debt|Company Short-Term Loans and Borrowings Trevi Therapeutics|Quick Ratio trevitherapeutics.com
- company profitability and valuation multiples indicators:
TRVI - Company Net Income|Forward Earnings Trevi Therapeutics|TRVI - P/E Multiple|Projected Price to Earnings Ratio trevitherapeutics.com|TRVI - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Trevi Therapeutics|TRVI - Operating profit before deduction of amortization|Earnings per share for the last four quarters Trevi Therapeutics|TRVI - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months trevitherapeutics.com|TRVI - Earnings growth in current year|Expected earnings per share growth for next year Trevi Therapeutics
Summary company analytics:Trevi Therapeutics
Trevi Therapeutics (TRVI) develops innovative treatments for severe pruritus and respiratory pathologies. An analysis of the current EBITDA_Co level demonstrates the real operational efficiency of the business, excluding depreciation and tax factors. This metric measures the company's ability to generate cash flow from its core operations. The stability of this indicator confirms the financial resilience of the biotech startup, allowing investors to assess capital protection during periods of macroeconomic recession.
Competitors of Trevi Therapeutics (TRVI)
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|NBIX: Operating profit before deduction of amortization|RGC: Profit before payment of interest, taxes and amortization|AXSM: Operating profit EBITDA|ACAD - Operating income before deduction of amortization|Operating profit before deduction of amortization XENE|VKTX: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization SUPN (Supernus Pharmaceuticals)|Company profit before taxes, interest and amortization CPRX|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Income before deduction of interest, taxes and amortization HRMY|Biohaven Pharmaceutical - Operating profit EBITDA|Profit before interest, taxes and amortization Amylyx Corp|Praxis Precision Medicines (PRAX) - Profit before payment of interest, taxes and amortization|anavex.com - Income before deduction of interest, taxes and amortization|CBLL (CeriBell) - Operating profit EBITDA|Operating profit EBITDA Prothena Corporation PLC|Profit before payment of interest, taxes and amortization Alector, Inc. (ALEC)|ANNX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA OMER (Omeros)|neurogene.com (NGNE) - Profit before interest, taxes and amortization|ACIU: Operating profit before deduction of amortization|VYGR - Operating profit EBITDA|NMRA (Neumora Therapeutics Inc) - Operating profit before deduction of amortization|SCLX: Company profit before taxes, interest and amortization|TVGN (Tevogen Bio Holdings) - Operating profit EBITDA|Alpha Cognition Corp (ACOG) - Operating income before deduction of amortization|Operating profit EBITDA CGTX|Operating profit before deduction of amortization Inhibikase Therapeutics Inc IKT|Profit before payment of interest, taxes and amortization Cassava SAVA|Operating income before deduction of amortization Assertio Holdings (ASRT)|COYA: Operating profit before deduction of amortization|Vistagen Therapeutics - Company profit before taxes, interest and amortization|ovidrx.com (OVID) - Profit before payment of interest, taxes and amortization|Acumen Pharmaceuticals Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CRVO|Profit before payment of interest, taxes and amortization ATHE|Operating profit EBITDA CLNN|Operating income before deduction of amortization pepgen.com|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD: Operating profit before amortization|Annovis Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience, Inc) - Operating profit before deduction of amortization|Klotho Neurosciences (KLTO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization NeuroSense Therapeutics Ltd|RVPH: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NRXS - Profit before interest, taxes and amortization|Helius Medical Technologies - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization PASG (Passage Bio Inc.)|NEUP - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NERV (Minerva Neurosciences Inc)|ATHA: Operating profit EBITDA|Profit before interest, taxes and amortization Addex (ADXN)|Operating profit before deduction of amortization ALZN|Profit before payment of interest, taxes and amortization CYCN|Operating profit EBITDA PTIX|Operating income before deduction of amortization pasitheaclinics.com|Cortigent - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ATXI|BCLI: Operating profit before deduction of amortization|caratherapeutics.com - Company profit before taxes, interest and amortization|CHRO: Operating profit EBITDA|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|ITCI (Intra-Cellular Therapies Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization Longboard LBPH|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NRBO (NeuroBo Pharmaceuticals, Inc.)|Operating profit EBITDA Sage Therapeutics Inc. SAGE|SNPX - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization TRVN|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Operating profit before deduction of amortization CERE
